http://www.polypid.com
PolyPid Ltd. Company Intro
ABOUT US We are a global clinical-stage bio-pharmaceutical company focused on developing, manufacturing and commercializing novel, locally administered therapies to improve surgical outcomes. Our PLEX (Polymer-Lipid Encapsulation matriX) technology is a unique platform that is anchored in the surgical site to provide controlled and continuous delivery of medications. Our product candidates are designed to deliver medications […]
Industry
Healthcare
PolyPid Ltd. Headquaters
18 Hasivim Street
Petach Tikva,4959376
Israel
PolyPid Ltd. Share price
17 May 2023 13:46 GMT
$0.3894
0.05 (14.53 %)
PolyPid Ltd. Market cap
$13.543 M
WMC RANKING
2024
PolyPid Ltd. # 428
BiotechnologyLatest PolyPid Ltd. News
12 Feb 2024
PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial
Approximately 40 Centers Currently Open Unblinded Interim Analysis to be Conducted Once Approximately 400 Patients Complete Their 30-Day Follow-up;...
12 Feb 2024
PolyPid makes progress in phase 3 trial for surgical infection prevention By Investing.com
PETACH TIKVA, Israel - PolyPid Ltd. (NASDAQ:PYPD), a biopharmaceutical company focused on improving surgical outcomes, has announced significant progress in...
12 Feb 2024
PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial
Approximately 40 Centers Currently Open Unblinded Interim Analysis to be Conducted Once Approximately 400 Patients Complete Their 30-Day Follow-up;...
WMC Market Score
WMC Market to Revenue Score
PolyPid Ltd. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| PolyPid Ltd. | USD | $0 | $30,633 | $-45,734 | $135M | 428 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total PolyPid Ltd. Social Followers vs Top 4 Industry Competitors
PolyPid Ltd. Post vs Top 4 Industry Competitors
PolyPid Ltd. Digital Footprint By Size vs Top 4 Industry Competitors
PolyPid Ltd. Digital Footprint By Change Rate vs Top 4 Industry Competitors
PolyPid Ltd. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| PolyPid Ltd. | 0 | 0.41 | 0.00 | 0 | 0 | 0 | 0.15 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
